Beste Urologen - TOP-476 Ärzte

EDUCATION INFORMATION

2000 Ankara Atatürk High School (English)

2006 Ankara University Faculty of Medicine (Medical Education)

2012 Ankara University Faculty of Medicine, Department of Urology (Specialty Training)

WORK INFORMATION

2006-2007 Zonguldak Ereğli No. 1 112 Emergency Medicine

2012-2013 Ankara Yenimahalle State Hospital (Urology Specialist)

2013-2014 Ardahan State Hospital (Urology Specialist)

2014-2015 Kars State Hospital (Urology Specialist)

2015-2021 Anadolu Medical Center (In Aff. With Johns Hopkins) Urooncology Center (Urology Specialist)

2021- Medicana Ataşehir Hospital Urology

February 2023.                          Spanish Field Hospital (“START” EMT2, Iskenderun Hatay)

SEMINARS and COURSES

September 2011 European Urology Residents Education Programme (EUREP) 9'th course Prague (CZ)

March 2016 Applied MR Fusion Biopsy Course in Early Diagnosis of Prostate Cancer (Acibadem University - Istanbul)

May 2017 1st Multiparametric Prostate MR Imaging Course (Turkish Society of Radiology) Istanbul

October 2019 3rd Multiparametric Prostate MRI and Targeted Prostate Biopsy Course (Istanbul University)

March 2023 da Vinci Robotic Surgery (Console Surgeon) Training, Intuitive (GLOBAL CASE: Acibadem University- Istanbul)

November 2022: CETAD / Istanbul Sexuality and Sexual Dysfunctions Disorders basic training.

June 2023: Brook .UK Relationship and Sex Education Training

Translated with DeepL.com (free version)

Prostate MR Fusion Biopsy

Uro-Oncologic Robotic Surgery

Testicular Tumors

Men's Health

Urinary System Stone Diseases

Urinary incontinence in women and children

Circumcision

Urological interventions in oncologic patients.  

Treatment of benign prostate enlargement (BPH)

Sexually transmitted diseases

Sexuality Education

Premature Ejaculation

Erectile Dysfunction Treatment

Penis and scrotum surgeries

Bladder Botox

Bladder Cancers

Kidney Tumors

HPV and wart treatment

Varicocele treatment  

• Renommierter Urologe, spezialisiert auf Prostatakrebs und minimalinvasive Chirurgie.
• Expertise in der Roboterchirurgie mit dem Da Vinci-System für urogenitale Erkrankungen.
• Zu den internationalen Praxen gehört Spanien und er ist Pionier in der transvaginalen Nephrektomie.
• Über 500 erfolgreiche urologische Operationen durchgeführt.
• Bemerkenswert für laparoskopische und robotergestützte urologische Eingriffe.
• Bekannt für die Behandlung von Nieren-, Blasen-, Nebennieren- und Hodenkrebs.
• Behandelt angeborene urologische Pathologien bei Kindern.
• Mitglied der American Urological Confederation – globale Standards für die Urologie.
• Teil der Urologischen Vereinigung Spaniens – nationale urologische Exzellenz.
• Verbunden mit der European Urological Society – kontinentale urologische Forschung.
• Bietet Online-Konsultationen und verbessert den Zugang zu spezialisierter urologischer Versorgung.

Education:

Medical Degree: Çukurova University Faculty of Medicine (1993)

Specialization in Urology: Şişli Etfal Training and Research Hospital (2005)

Professional Experience:

Current Position: Practicing at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul

Past Experience: Extensive work in both public and private healthcare sectors, including significant contributions at Istanbul İstinye University Health Practice and Research Center.

Areas of Interest:

Pediatric Urology

Urogynecology

Treatment of pediatric urology disorders

Urological surgeries and procedures

Professional Memberships:

Member of several prestigious medical societies, including the Turkish Medical Association, European Society of Pediatric Urology, and the Turkish Society of Pediatric Urology.

Certifications:

Dr. Güllüoğlu has completed numerous certifications and advanced training programs, reflecting his commitment to continuous professional development and staying at the forefront of urological advancements.

Prof. Montorsi ist einer der führenden italienischen Experten für Urologie und Andrologie mit zahlreichen wissenschaftlichen Auszeichnungen und mehr als 8.000 Urologie-/Andrologie-Operationen. Er leitet das Urologische Forschungsinstitut (URI) in Italien, gilt als einer der einflussreichsten Forscher des letzten Jahrzehnts und hat seine Venenpflastermethode entwickelt, um eine okklusive Venendysfunktion zu korrigieren. Er ist Ehrenmitglied des Royal College of Surgeons of England und hat über 1.000 Artikel verfasst. Er ist Mitglied verschiedener medizinischer Organisationen.

Dr. Sılay is an experienced pediatric urologist practicing in Turkey.

Specialty

Assoc. Prof. Selçuk Sılay specializes in robotic surgery for urology conditions in children.

Dr. Selçuk Sılay has provided over:

• 300 pediatric laparoscopic surgeries
• 100 pediatric robotic surgeries
• 300 closed kidney stone surgeries in children.

Work experience

• Since 2018 – Urologist in Memorial Bahçelievler Hospital and Memorial Ataşehir Hospital
• 2017-2018 – Pediatric urology robotic surgery specialist in Mehmet Akif Ersoy Training and Research Hospital
• 2016-2018 – Head of Pediatric Urology Department in Istanbul Medeniyet University Göztepe Training and Research Hospital
• 2011-2016 – Head of Pediatric Urology Department at the Bezmialem Foundation University
• 2009 – Urology Specialist in Diyarbakir Bismil State Hospital
• 2006-2007 – Urology and Robotic Surgery Specialist.

Education

• 1997-2003 – Ankara University Medical School – Degree in general medicine
• 2003 – Baylor College of Medicine (USA) – Training in urology
• 2004-2009 – Istanbul Şişli Hamidiye Etfal Education And Research Hospital – Training in urology
• 2006-2007 – Baylor College of Medicine (USA) – Internship in urology
• 2014-2015 – Texas Children's Hospital (USA) – Pediatric Urology Robotic Surgery Training (USA).

Awards

• 2016 Young Academician of the Year Award by the 24th National Urology Congress in Cyprus
• 2018 Crystal Matula Award as European Academician of the Year.

Scientific activity

Prof. Selçuk Sılay provides research in robotic surgery in children. Has written over 80 articles.

Membership in organizations

• The Turkish Society of Pediatric Urology
• The European Association of Urology
• The European Society for Paediatric Urology
• The Turkish Association of Urology.

Education:

1997 – 2003    Hacettepe University

2004 – 2009     Ankara Dışkapı Training and Research Hospital

2016 – 2019     Afyon Kocatepe University

Experience:

2022 – Still       Lokman Hekim Akay Hospital

2019 – 2022     Private Meddem Hospital

2018 – 2019      Afyon Kocatepe University

2015 – 2018      Afyon Kocatepe University

2012 – 2015      Bozok University Faculty of Medicine

2010 – 2012     Ankara Dışkapı Training and Research Hospital

2009 – 2010      TSK Rehabilitation and Care Center Presidency

2004 – 2009     Ankara Dışkapı Training and Research Hospital

After graduating in Medicine and Surgery, Dr. Saltutti specialized in Urology, gaining advanced expertise in treating disorders of the male and female urinary system, as well as the male reproductive system. Throughout his professional journey, he has focused on innovative and minimally invasive surgical techniques, such as robotic and laparoscopic surgery, especially for the treatment of prostate, kidney, and bladder cancers.

Over the years, Dr. Saltutti has attended numerous national and international conferences, expanding his knowledge and contributing to the advancement of therapeutic and surgical techniques in the urological field. He is known for his clinical expertise and dedication to his patients, adopting a personalized approach to each case to ensure effective, high-quality care.

His work at GVM facilities, which boast cutting-edge technologies and a highly qualified medical team, allows Dr. Saltutti to offer comprehensive services ranging from early diagnosis to treatment and post-operative rehabilitation. His areas of specialization include, in addition to urological cancers, the treatment of prostate conditions, kidney stones, urinary incontinence, and male sexual dysfunction.

Thanks to his experience and passion for the medical profession, Dr. Carlo Saltutti is a reference point for patients seeking excellent urological care at the GVM group

Specialties

Kidney and urinary tract endoscopic stone crushing treatment

Endoscopic Prostate and Bladder Surgery (TUR Method)

Diagnosis and surgery of testicular diseases

Diagnosis and treatment of infertility in men (Varicocele surgeries)

Diagnosis and treatment of sexual dysfunctions

Treatment of urinary incontinence in women

Treatment of nocturnal incontinence in children

Treatment of undescended testicle in children

Circumcision

Experience

1995-1999 Bilecik State Hospital Urology Clinic

1999-2002 Kocaeli Gölcük State Hospital Urology Clinic

2002-2006 Sakarya Karasu State Hospital Urology Clinic and Chief Physician

2006-2012 Kocaeli State Hospital Urology Clinic and Chief Physician

2012-2015 Kocaeli State Hospital Urology Clinic

2015-2018 Kocaeli Public Hospitals Secretary General

2018-2021 Kocaeli Provincial Health Director

2021-2023 Kocaeli Darıca Farabi Training and Research Hospital Urology Clinic

2023- 2024 Kocaeli Gölcük Necati Çelik State Hospital Urology Clinic

2024 Private Darıca Büyük Anadolu Hospital

Education

Uludag University Faculty of Medicine (graduation) 1988

Selcuk University Faculty of Medicine (specialization) 1994

1982-1988 Uludağ University Faculty of Medicine

1990 -1994 Selcuk University Faculty of Medicine, Department of Urology (Specialization)

Scientific Publications

Acar A., Sert I. Ü., Gürbüz R., Ergüney Ş: Submucosal methotrexate applications in inoperable bladder tumors.  S.Ü.T.F. Journal. 1993; 9(1):39-41

Acar A., Sert İ.Ü., Gürbüz R., Arslan E.M., Ergüney Ş. , : Bladder wall and prostate

Translated with DeepL.com (free version)

Dr. Ivan Colombo ist ein erfahrener Urologe mit 30 Jahren Erfahrung und Spezialisierung auf Roboterchirurgie, Behandlung urologischer Erkrankungen und Onkologie. Derzeit arbeitet er im St. Zdislava-Krankenhaus und ist Mitglied verschiedener angesehener Organisationen, darunter der Urologischen Gesellschaft der Tschechischen Republik, der Chirurgischen Gesellschaft der Tschechischen Republik, der Vereinigung für Roboterchirurgie, der European Urology Association, der American Urology Society und der International Urology Society. Er hat außerdem über 150 Artikel in nationalen und internationalen Fachzeitschriften veröffentlicht.

Dr. Ayan graduated from Medical School in 1991 and completed his urology education in 1997. At the beginning of his carrier, he was a post doctorate research fellow at the Department of Urology of Harvard Medical School, Children’s Hospital in Boston (1999-2000). He studied the effect of partial ureteral obstruction to the kidney in early developmental stage in an experimental animal fetus model. This study provided a significant contribution to a complicated issue of pediatric urology and was cited many times by its successors. 

He became associate professor of urology in 2004 and was appointed as a professor of urology in 2009. He was accepted as a clinical fellow in Minimal Invasive Urologic Oncology at the Department of Surgery, Section of Urology at the University of Chicago (2014-2015). He worked in an intense oncology program mainly concentrated on robotic surgery of prostate and kidney cancer. Because of this background, he is mainly interested in urologic oncology and pediatric urology. The primary portion of his daily practice consist of kidney cancer, prostate cancer, bladder cancer, neonatal hydronephrosis, ureteropelvic junction obstruction, urine reflux to kidney, hypospadias and undescended testis. 

Because of its prevalence in Turkey, Prof. Ayan has a huge experience with urinary stone disease and he is doing large number of endoscopic and percutaneous surgeries for kidney, ureter and bladder stones. 

Prof. Ayan holds United States Medical License and European Board of Urology Certificate. He is a member of AUA, EAU and Turkish Urologic Surgery and Urologic Oncology Societies. 

List of International Scientific Publications; 

1. Ayan S, Yildirim S, Ucar C, Sarioglu Y, Gültekin EY, Butuner C. Corporal reactivity to adenosine and prostaglandin E1 in alloxan-induced diabetic rabbit corpus cavernosum and the effect of insulin therapy. BJU Int, 83: 108-12, 1999. 

2. Yildirim S, Ayan S, Sarioglu Y, Gültekin EY, Butuner C. The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int, 83: 679-85, 1999. 

3. Ayan S, Kaloglu C, Gökce G, Kılıcarslan H, Gültekin EY. Effect of insulin therapy to diabetic cystopathy: urodynamic and histological findings in a rabbit model. Sc J Urol Nephrol, 33: 392-5, 1999. 

4. Yildirim S, Ayan S, Sarioglu Y, Gültekin Y, Uma S. Does diabetes mellitus affect the progress of tolerance to isosorbide dinitrate (ISDN) in corporal tissue? Nitric Oxide: Biology and Chemistry, 4: 29- 34, 2000. 

5. Ayan S, Sarioglu Y, Yildirim S, Gokce G, Bagcıvan I. Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU Int, 87(3):265-8, 2001. 

6. Ayan S, Gokce G, Kılıcarslan H, Kaya K, Gultekin EY. An unusual cause of urinary incon tinence: urethral coitus. Sc J Urol Nephrol, 35:254, 2001. 

7. Yildirim S, Simsek R, Ayan S, Gokce G, Sarıoğlu Y, Safak C. Relaxant effect of some benzothiazolinone dervatives on isolated rabbit corpus cavernosum. Urol Res, 29:182-5, 2001. 

8. Ayan S, Roth JA, Freeman MR, Bride SH, Peters C. Partial ureteral obstruction dysregulates the RAS in the fetal sheep. Urology, 58: 301-6, 2001. 

9. Kılıcarslan H, Ayan S, Gokce G, Kaya K, Gultekin EY. Cranial blind ending branch of a bifid ureter. Int Urol Nephrol, 32: 635-6, 2001. 

10. Gokce G, Kılıcarslan H, Ayan S, Yıldız E, Kaya K, Gultekin EY. Adenomatoid tumors of testis and epididym: a report of two cases. Int Urol Nephrol, 32:677-80, 2001. 

11. Ayan S, Gokce G, Kılıcarslan H, Ozdemir O, Yildiz E, Gultekin EY. K-RAS mutation in transitional cell carcinoma of urinary bladder. Int Urol Nephrol, 33:363-67, 2001. 

12. Bulut HE, Onarlıoglu B, Kaloglu C, Özdemir Ö, Ayan S. Effects of experimental diabetes and insulin treatment on rabbit renal morphology: a quantitative and qualitative study. Turk J Med Sci, 31: 209-16, 2001. 

13. Kılıcarslan H, Gokce G, Ayan S, Gultekin EY, Arıkan Y, Hocaoglu S. Fournier’s gangrene: a report of 20 cases. T Klin J Med Res 19:55-58, 2001. 

14. Gokce G, Kılıcarslan H, Ayan S, Tas F, Akar R, Kaya K, Gultekin EY. Genitourinary tuberculosis: A review of 174 cases. Scand J Infect Dis, 34: 338-40, 2002. 

15. Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y. Effect of chronic renal failure (CRF) on purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 90(6):596-600, 2002. 

16. Bagcivan I, Gokce G, Ayan S, Yildirim S, Sarac B, Kilicarslan H, Sarioglu Y. Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.Int J Urol.;9(11):641-4; discussion 645, 2002. 

17. Bagcivan I, Kilicarslan H, Sarac B, Gokce G, Yildirim S, Ayan S, Sarioglu Y. The evaluation of the effects of renal failure on erectile dysfunction in a chronic renal failure (CRF) rabbit model. BJU Int.;91(7):697-701, 2003 

18. Kilicarslan H, Guvenal T, Ayan S, Gokce G, Cetin A, Gultekin Y. Comparison of outcomes of three different surgical techniques performed for stress urinary incontinence. Int J Urol.;10(3):126- 30, 2003. 

19. Kaya S, Poyraz O, Gökçe G, Kılıçarslan H, Kaya K and Ayan S. Role of Genital Mycoplasmata and Other Bacteria in Urolithiasis. Scand J Infect Dis, 35:315-317,2003. 

20. Kilicarslan H, Gokce G, Ayan S, Atalar M, Kaya S, Kaya K, Gultekin Y. A case of hydatid disease: urinary retention due to isolated retrovesical hydatid cyst in a boy. Scand J Infect Dis, 35 :408-410, 2003. 

21. Gokce G, Kaya K, Kılıcarslan H, Tas F, Ayan S, Yıldız E, Gultekin E Y. Epidermoid cyst in the renal pelvis. Int Urol Nephrol;35(1):9-10, 2003. 

22. Kilicarslan H, Gokce G, Ayan S, Guvenal T, Kaya K, Gultekin EY. Predictors of outcome after in situ anterior vaginal wall sling surgery. Int Urogynecol J Pelvic Floor Dysfunct ;14(5):339-41, 2003. 

23. Kilicarslan H, Gokce G, Kaya K, Ayan S, Gultekin YE. Surgical treatment of penil fractures. Ulus Travma Derg.;9(1):54-6, 2003. 

24. Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze F, Gultekin EY. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int. 2004 ;93(7):1087-93. 

25. Gokce G, Topsakal K, Ayan S, Kilicarslan H, Gokce SF, Gultekin EY. Case report: Nonobstructive giant urethral stone with two safety pins. Int Urol Nephrol. 2004;36(1):65-6. 

26. Kaya K, Ayan S, Gokce G, Kılıcarslan H, Yildiz E, Gultekin EY. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma. Scand J Urol Nephrol. 38 :1-5,2004. 

27. Ayan S, Kaya K, Topsakal K, Kılıçarslan H, Gokce G, Gültekin Y. Efficacy of tolterodine as a firstline treatment for non-neurogenic voiding dysfunction in children. BJU Int. 96(3):411-4, 2005. 

28. Kaya K, Gokce G , Kaya S, Kilicarslan H, Ayan S, Gultekin EY. Isolated renal and retropertoneal hydatid cysts: a report of 23 cases. Trop Doct. 2006 Oct;36(4):243-6. 

29. Candan F, Ayan S, Tas F, Gokce G, Elagoz S. Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int, 25(6):475-7, 2005. 

30. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest, 24(1):41-5, 2006. 

31. Tanzer F, Ozgur A, Bardakci F, Cankorkmaz L, Ayan S. Analysis of a 1-year-old cystinuric patient with recurrent renal stones. Int J Urol. 13(10):1347-9, 2006. 

32. Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY.Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol. 2006;38(3-4):537-41. 

33. Ayan S, Topsakal K, Gokce G, Gultekin EY.Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol. 2007 Jun;177(6):2325-8; discussion 2328-9. 

34. Ozdemir O, Gul E, Kilicarslan H, Gokce G, Beyaztas FY, Ayan S, Sezgin I.SRY and AZF gene variation in male infertility: a cytogenetic and molecular approach. Int Urol Nephrol. 2007;39(4):1183-9. 

35. Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2008 Mar;101(6):758-64. 

36. Kenan Kaygusuz, Gokhan Gokce, Iclal Ozdemir Kol, Semih Ayan and Sinan Gursoy. Efficacy of Preventive Analgesia with Tramadol or Lornoxicam for Percutaneous Nephrolithotomy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Current Therapeutic Research 68(4), 205-216, 2007. 

37. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y.A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: a randomized controlled trial. Anesth Analg. 2008 Jan;106(1):114-9. 

38. Gokce G, Karboga H, Yildiz E, Ayan S, Gultekin Y. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on apoptotic changes in contralateral testis following unilateral testicular torsion. Int Urol Nephrol. 2008;40(4):989-95. 

39. Ozdemir, O (Ozdemir, Oztuerk); Yildiz, E (Yildiz, Esin); Ayan, S (Ayan, Semih); Gul, E (Gul, Eylem)1; Gokce, G (Gokce, Goekhan); Yildiz, F (Yildiz, Fazilet)1; Koksal, B (Koksal, Binnur)1; Goze, F (Goze, Fahrettin); Gultekin, EY (Gultekin, E. Yener). Epigenetic alterations and oncogenes mutations in urinary bladder carcinomas.CHROMOSOME RESEARCH. 2009, Volume: 17 Supplement: 1 Pages: 171-171 

40. Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K; Turkish Validation Study Group of Kattan Preoperative Nomogram, Kattan MW, Ozen H. Collaborators: Yildirim A, Yazici S, Divrik RT, Ozkardeş H, Koşan M, Kurtuluş FO, Büyükalpelli R, Mungan A, Lekili M, Sahin H, Günlüsoy B, Ayan S, Bozlu M. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Urooncology Society. Urology. 2009 Dec;74(6):1289-95. 

41. Ozdemir O, Yildiz S, Ayan S, Gül E, Gokce G, Yildiz F, Koksal B. Promoter hypermethylation of tissue specific tumor supressor genes and point mutation in K-ras, c-myc proto-oncogenes in urinary (transitional cell) bladder carcinoma. Health. 2010; 2(8):850-856. 

42. Türkeri L, Tanıdır Y, Çal Ç, Özen H, Şahin H; Collaborators :Kaya C, Karaman İ, Şengör F, Alkibay T, Sözen S, Büyükalpelli R, Can C, Kuyumcuoğlu U, Albayrak S, Abay E, Soyupak B, Tansuğ Z, Fazlıoğlu A, Gültekin Y, Ayan S, Gümüş E, Lekili M, Dillioğlugil Ö, Özer G, Uygur C, Akpınar H. Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study. Urol Int. 2010;85(3):261-5. 

43. Kuzgunbay B, Yaycioglu O, Soyupak B, Atay Kayis A, Ayan S, Yavascaoglu I, Cal C, Beduk Y; Turkish Study Group of Public Awareness in Testicular Cancer Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society.Urol Oncol. 2011 Mar 22. Epub ahead of print] 

44. Biçer H, Korgali E, Gökçe G, Ayan S, Yıldırım S, Gültekin EY. Contractile responses of urinary bladder in an experimental model of chronic renal failure. Bosn J Basic Med Sci. 2012 Nov;12(4):219- 23. 

45. Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 2013 Jan;43(1):63-8. 

46. Erden Y, Korgalı E, Dundar G, Ayan S, Gokce G, Yildirim S, Gultekin EY. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle. Arch Ital Urol Androl. 2014 Mar 28;86(1):33-8.

2021 - Currently, İstanbul/Türkiye

MEMORIAL ŞİŞLİ HOSPITAL

Urology Specialist

2018 - 2018, Hamburg/Germany

HAMBURG-EPPENDORF UNIVERSITY HOSPITAL

Urology & Reconstructive Urology Specialist

2017 - 2018, İstanbul/Türkiye

MEHMET AKİF ERSOY CARDIOVASCULAR SURGERY HOSPITAL

Urology & Robotic Surgery Specialist

2015 - 2021, İstanbul/Türkiye

HASEKİ EDUCATION AND RESEARCH HOSPITAL

Urology Clinic Lecturer

2011 - 2013, Siirt/Türkiye

SİİRT STATE HOSPITAL

Urology Specialist

EDUCATION Ankara Training and Research Hospital, Urology Specialization Training, 1992-1997, Ankara/Türkiye Uludağ University Faculty of Medicine, Medical Doctor Education, 1982-1988, Bursa/Türkiye

EXPERIENCE Taksim Training and Research Hospital, 2009-2016, Istanbul/Türkiye Bağcılar Training and Research Hospital, 2007-2009, Istanbul/Türkiye Ankara Training and Research Hospital, 2000-2007, Ankara/Türkiye Bergama State Hospital, 1997-2000, Izmir/Türkiye Ankara Training and Research Hospital, 1992-1997, Ankara/Türkiye

- Turkish Urology Association

- European Association of Urology

- Turkish Urology Association Northern Marmara

- American Urological Association

Assoc. Prof. Dr. Cenk Acar completed his medical education at Ankara University Faculty of Medicine and his urology residency at Gazi University Faculty of Medicine, Department of Urology. He worked as an assistant professor at Pamukkale University Faculty of Medicine, Department of Urology between June 2009 and November 2012. Between May 2012 and November 2012, he worked as a fellow in robotic and laparoscopic surgery in urologic cancers for 6 months in the Urology Department of “The Netherland Cancer Institute-AVL hospital”. He started to work at Acıbadem Ankara Hospital in November 2012. In September 2014, he completed the necessary academic qualifications and received the title of “Associate Professor”. After working in a private hospital in Ankara between 2015-2020, he continued his services in his private practice in Ankara until 2020 when he started Hisar Intercontinental Hospital.

In 2015, he was the chairman of the organizing committee of the first course on ‘Fluorescence Imaging in Urological Surgery’ in the field of urology in Turkey. In the following years, he chaired many urology and multidisciplinary courses on ICG fluorescence imaging under the umbrella of Urology Associations. In 2017, for the first time in Turkey, he started to apply Bipolar Prostate Enucleation in benign prostate enlargement in his clinic. Later, he started to use his increasing experience in surgeries such as HOLEP and THUFLEP.

In his career, Dr. Acar, who is especially interested in Urological Cancers, Urinary System Stones, HOLEP, THUFLEP, Endourology, and Robotic and Laparoscopic Urological Surgeries, has carried out many successful operations. He has performed over 500 urological cancer surgeries, over 250 HOLEP surgeries, countless endoscopic stone surgeries, and numerous robotic and laparoscopic surgeries.

FIELDS OF MEDICAL INTEREST

• Localized Prostate Cancer Treatments
• Quality of Life in Urological Cancers
• Sentinel Lymph Node Dissections in Prostate Cancer
• Intraoperative Fluorescence Imaging Techniques in Robotic and Laparoscopic Urological Surgery
• Prostate Enucleations in BPH (HOLEP, BIPOLEP, THULEP)
• Urinary System Stone Disease